Cargando…
Does lineage plasticity enable escape from CAR-T cell therapy? Lessons from MLL-r leukemia
The clinical success of engineered, CD19-directed chimeric antigen receptor (CAR) T cells in relapsed, refractory B-cell acute lymphoblastic leukemia (B-ALL) has generated great enthusiasm for the use of CAR T cells in patients with cytogenetics that portend a poor prognosis with conventional cytoto...
Autores principales: | Liao, Wenjuan, Kohler, M. Eric, Fry, Terry, Ernst, Patricia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611617/ https://www.ncbi.nlm.nih.gov/pubmed/34298117 http://dx.doi.org/10.1016/j.exphem.2021.07.002 |
Ejemplares similares
-
MLL rearrangements in pediatric acute lymphoblastic and myeloblastic leukemias: MLL specific and lineage specific signatures
por: Zangrando, Andrea, et al.
Publicado: (2009) -
The developmental stage of the hematopoietic niche regulates lineage in MLL-rearranged leukemia
por: Rowe, R. Grant, et al.
Publicado: (2019) -
3′UTR-Mediated Gene Silencing of the Mixed Lineage Leukemia (MLL) Gene
por: Gomez-Benito, Maria, et al.
Publicado: (2011) -
Epigenetic regulator genes direct lineage switching in MLL/AF4 leukemia
por: Tirtakusuma, Ricky, et al.
Publicado: (2022) -
CD133-directed CAR T-cells for MLL leukemia: on-target, off-tumor myeloablative toxicity
por: Bueno, Clara, et al.
Publicado: (2019)